New Adjuvant Treatment Strategies for Early-Stage HER2-Positive Breast Cancer: Clinical and Shared Decision Making Implications for the Oncology Nurse

Slideset - These downloadable slides, from our live meeting series on adjuvant therapy for HER2+ EBC, review the current clinical rational and most recent data on dual HER2-targeted adjuvant therapy with trastuzumab and pertuzumab as well as the use of extended therapy with neratinib for patients at high risk of disease recurrence.
Source: Clinical Care Options Breast Cancer - Category: Cancer & Oncology Source Type: research